A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Clinical trial NCT02763566 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02763566
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-05
- Primary completion
- 2019-03-29
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.